newsfilter
← Latest News
GlobeNewswire·

Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights

Patient enrollment in the Phase 1b hemodynamic trial remains ahead of expectation, with topline results now expected in late Q1'2025 or early Q2'2025First subject dosed with TX000045 ("TX45") in APEX Phase 2 clinical